Search

everythinglearnresearchcommunity

for

Search:↓

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Finasteride, a drug that changes testosterone to a different hormone, was studied and its effects over time were modeled successfully.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

Human hair follicles may provide a noninvasive way to diagnose diseases and have potential in regenerative medicine.

Liposomes better deliver minoxidil for hair loss treatment than niosomes.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Terazosin and finasteride together cause no major issues.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

Raman spectroscopy is promising for measuring and enhancing drug delivery in alopecia treatments.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Enzymatically extracted bear oil has more unsaturated fats and significantly increases hair growth in mice.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Method accurately measures finasteride in tablets using finasteride-BSA interaction.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Tofacitinib may help treat severe hair loss, but more research is needed.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Clascoterone is safe for the heart, even at high doses.

Side effects of drugs can lead to the discovery of new treatments.

The Shen Bai Hair Growing Decoction may help treat hair loss by promoting hair growth and reducing inflammation.

The drug combination was safe and showed promise in treating advanced tumors.

The document concludes that developing generic topical drugs requires ensuring they match the original in quality, composition, and structure, and often involves complex testing and regulatory steps.

Finasteride's effect on hair loss and prostate enlargement depends on its binding to an enzyme, with maximum impact at 0.2 mg dose.

Paeoniflorin protects brain cells by involving a specific protein and neurosteroids.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.